Oh, Sangwook http://orcid.org/0000-0003-0092-9031
Mao, Xuming http://orcid.org/0000-0003-4232-8103
Manfredo-Vieira, Silvio http://orcid.org/0000-0001-8036-4223
Lee, Jinmin
Patel, Darshil
Choi, Eun Jung
Alvarado, Andrea
Cottman-Thomas, Ebony
Maseda, Damian http://orcid.org/0000-0003-0722-6881
Tsao, Patricia Y. http://orcid.org/0000-0002-8800-1846
Ellebrecht, Christoph T.
Khella, Sami L.
Richman, David P.
O’Connor, Kevin C. http://orcid.org/0000-0002-7056-419X
Herzberg, Uri
Binder, Gwendolyn K.
Milone, Michael C.
Basu, Samik
Payne, Aimee S. http://orcid.org/0000-0001-9389-7918
Funding for this research was provided by:
National Research Foundation of Korea (2019R1A6A3A03033057)
No Grant number funding for Cabaletta Bio
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01-AI114780, R21-AI142198, R01-AI114780, R21-AI142198)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 22 March 2022
Accepted: 8 December 2022
First Online: 19 January 2023
Competing interests
: S.O. is involved with patent licensing from Cabaletta Bio. J.L., D.P., A.A., E.C.-T., U.H., G.K.B. and S.B. are employed by Cabaletta Bio. C.T.E. is involved with equity and patent licensing from Cabaletta Bio and patent licensing from Novartis. S.L.K. is a consultant for Catalyst, Alexion and Argenx. D.P.R. obtained a research grant from Cabaletta Bio. K.C.O. is involved with equity and obtained a research grant from Cabaletta Bio; is involved with research support, is a consultant and has received speaker fees from Alexion/AstraZeneca; has provided research support and received speaking fees from Viela Bio/Horizon Therapeutics; and is a consultant for and has received speaking fees from Roche and received speaking fees from Genentech and UCB. M.C.M. is involved with equity and has received payment, a research grant and patent licensing from Cabaletta Bio, as well patent licensing from Novartis and Tmunity, and is involved with equity and has received patent licensing from Verismo. A.S.P. is involved with equity, has received payment, research grant and patent licensing from Cabaletta Bio and patent licensing from Novartis, and is a consultant to Janssen. X.M., S.M.-V., E.J.C., D.M. and P.Y.T. declare no competing interests.